There are about 106 peptide and nanobody drug conjugates in active development, and around 63% of them are still preclinical, according to a 2026 Citeline analysis of Pharmaprojects data.¹ For most of ...
A new preclinical study suggests that attacking triple-negative breast cancer (TNBC) in two ways at once can kill cancer ...
A prototype drone carried a gold-nanoparticle lateral-flow sensor that detected dengue antigen at 0.91 micrograms per ...
HONG KONG, SHANGHAI and FLORHAM PARK, N.J., Oct. 20, 2026 (GLOBE NEWSWIRE) -- (“HUTCHMED” or the “Company”) (Nasdaq/AIM:HCM; HKEX:13) today announces that further to its announcement on September 3, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results